Latest Articles

This article examines how the understanding of regulatory T cells transformed from initial scientific doubt to Nobel Prize-winning research.

In this interview, Dr. Neil Sheppard, director of the Therapeutic Innovation in Natural Killer cells (THINK) lab at the University of Pennsylvania, discusses the challenges involved in developing new CAR-based treatments.

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the effects of specific genetic variants on cancer cell physiology.

Technology Networks spoke with Dr. Samantha Pearman-Kanza to learn more about the benefits (and potential pitfalls) of going paperless in the lab and some of the research advancing digital technologies.

Dr. Tyler Brown discusses his experiences of working in STEMM and highlights how the industry can foster a more inclusive workplace culture.

This article explores how epigenetic mechanisms control gene expression, how their disruption drives cancer and how targeting these processes is reshaping cancer diagnosis and treatment.

How can research labs reduce their environmental impact? Technology Networks asked two sustainability experts to find out.

Dr. Stephen Schoenberger, a professor at La Jolla Institute for Immunology, explores how recent discoveries and emerging tools are reshaping the field and what they could mean for the future of personalized cancer treatment.

The rise of digital science is reshaping lab sustainability. In this article, experts highlight the need for new standards to account for computing’s growing environmental impact.

Learn how in vitro models mimic tumors and aid in oncology research, paving the way for safer and more effective cancer therapies.